Metraipolis › archive › dc_1df782ade3cb
Safety and efficacy of AST-001 in children with autism spectrum disorder: a 52-week multicenter long-term follow-up study — Europe PMC PMID:42305848
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42305848
- DOI
- 10.3389/fpsyt.2026.1783915
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T21:13:41.789Z
- SHA-256 of the archived text
9376ff4c68c49c652086801faf2b392e6923772a059c2c5349e9eccf5dd1409c- Stable URL of this page
https://metraipolis.com/documento/dc_1df782ade3cb
How to cite
Safety and efficacy of AST-001 in children with autism spectrum disorder: a 52-week multicenter long-term follow-up study — Europe PMC PMID:42305848 — Europe PMC (en), https://europepmc.org/article/MED/42305848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1df782ade3cb (Metraipolis archive dc_1df782ade3cb, sha256 9376ff4c68c49c652086801faf2b392e6923772a059c2c5349e9eccf5dd1409c)
BibTeX
@misc{dc1df782ade3cb,
title = {Safety and efficacy of AST-001 in children with autism spectrum disorder: a 52-week multicenter long-term follow-up study — Europe PMC PMID:42305848},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42305848},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1df782ade3cb; sha256 9376ff4c68c49c652086801faf2b392e6923772a059c2c5349e9eccf5dd1409c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42305848. Agents can read the archived copy with the MCP tool read_document.